Utilizing a MYC-driven model of T-ALL, Anderson and colleagues demonstrated that heterozygous inactivation of DLST (the E2 enzyme of KGDHC) was sufficient to significantly delay tumor onset without impacting normal animal development (Anderson et al., 2016). Here, MYC is linked to neoplasm.